Tazarotene Patent Expiration
Tazarotene is Used for treating acne vulgaris in patients 12 years of age or older. It was first introduced by Allergan Inc
Tazarotene Patents
Given below is the list of patents protecting Tazarotene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Arazlo | US11311482 | Topical compositions and methods for treating skin diseases | May 11, 2038 | Bausch |
| Arazlo | US11679116 | Topical compositions and methods for treating psoriasis | Jun 06, 2036 | Bausch |
| Arazlo | US6517847 | Topical gel delivery system |
Aug 03, 2020
(Expired) | Bausch |
| Fabior | US10568859 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Fabior | US10688071 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Fabior | US8808716 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Tazorac | US5914334 | Stable gel formulation for topical treatment of skin conditions |
Jun 07, 2014
(Expired) | Allergan |
| Tazorac | US6258830 | Stable gel formulation for topical treatment of skin conditions |
Jun 07, 2014
(Expired) | Allergan |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Tazarotene Generics
Several generic applications have been filed for Tazarotene. The first generic version for Tazarotene was by Taro Pharmaceuticals Inc and was approved on Apr 3, 2017. And the latest generic version is by Padagis Israel Pharmaceuticals Ltd and was approved on Apr 25, 2023.
Given below is the list of companies who have filed for Tazarotene generic.
1. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Tazarotene. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Prescription | TOPICAL | AB | Apr 3, 2017 |
2. COSETTE
Cosette Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Prescription | TOPICAL | AB | Sep 13, 2022 |
| 0.05% | gel | Prescription | TOPICAL | AB | Sep 13, 2022 |
3. FOUGERA PHARMS INC
Fougera Pharmaceuticals Inc has filed for 1 generic for Tazarotene. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Discontinued | TOPICAL | N/A | Jan 28, 2019 |
4. SOLARIS PHARMA CORP
Solaris Pharma Corp has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Solaris Pharma Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | gel | Prescription | TOPICAL | AB | Mar 20, 2023 |
| 0.1% | gel | Prescription | TOPICAL | AB | Mar 20, 2023 |
5. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Prescription | TOPICAL | AB | Apr 25, 2023 |
| 0.05% | gel | Prescription | TOPICAL | AB | Apr 25, 2023 |